Markus Tolnay

16.9k citations

124 papers · 10.9k indexed · 3 hit papers · h-index 50

Impact in

Neurology top 0.1%
- Parkinson's Disease Mechanisms and Treatments
- Neurological diseases and metabolism
- Neuroinflammation and Neurodegeneration Mechanisms
Physiology top 0.2%
- Alzheimer's disease research and treatments

Papers in ⓘ

Neurology 38
- Neurological diseases and metabolism 29
- Parkinson's Disease Mechanisms and Treatments 26
- Neuroinflammation and Neurodegeneration Mechanisms 8
Physiology 61
- Alzheimer's disease research and treatments 61

Co-authors: A. Probst (38 shared papers)Michel Goedert (19 shared papers)Florence Clavaguera (19 shared papers)Stephan Frank (19 shared papers)Matthias Staufenbiel (9 shared papers)Mathias Jucker (5 shared papers)R. Anthony Crowther (4 shared papers)Graham Fraser (4 shared papers)
Journals: Acta Neuropathologica (16 papers)Neuropathology and Applied Neurobiology (6 papers)Brain Pathology (4 papers)Advances in experimental medicine and biology (4 papers)PLoS ONE (4 papers)
Partner nations: Switzerland United Kingdom Germany

In The Last Decade

Markus Tolnay

124 papers receiving 10.8k citations

Hit Papers

align trajectories log scale

Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction 2020 · 834 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Histopathology
2013 Proceedings of the National Academy of Sciences
2009 Nature Cell Biology

Peers

Countries citing papers authored by Markus Tolnay

Since Specialization

Citations

This map shows the geographic impact of Markus Tolnay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Tolnay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Tolnay more than expected).

Fields of papers citing papers by Markus Tolnay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Tolnay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Tolnay. The network helps show where Markus Tolnay may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Tolnay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Tolnay Line = papers co-authored together Markus Tolnay links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Transmission and spreading of tauopathy in transgenic mouse brain Nature Cell Biology ·Florence Clavaguera, Tristan Bolmont, R. Anthony Crowther, Dorothée Abramowski, Stephan Frank, A. Probst, Graham Fraser, Anna K. Stalder, Martin Beibel, Matthias Staufenbiel, Mathias Jucker, Michel Goedert, Markus Tolnay Hit paper breakdown →	2009	1334
2	Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction Histopathology ·Thomas Menter, Jasmin D. Haslbauer, Ronny Nienhold, Spasenija Savic, Helmut Hopfer, Nikolaus Deigendesch, Stephan Frank, Daniel Turek, Niels Willi, Hans Pargger, Stefano Bassetti, Jörg D. Leuppi, Gieri Cathomas, Markus Tolnay, Kirsten D. Mertz, Alexandar Tzankov Hit paper breakdown →	2020	834
3	Brain homogenates from human tauopathies induce tau inclusions in mouse brain Proceedings of the National Academy of Sciences ·Florence Clavaguera, Hiroyasu Akatsu, Graham Fraser, R. Anthony Crowther, Stephan Frank, Jürgen Hench, A. Probst, David T. Winkler, Julia Reichwald, Matthias Staufenbiel, Bernardino Ghetti, Michel Goedert, Markus Tolnay Hit paper breakdown →	2013	563
4	Neuropathology in mice expressing human alpha-synuclein PubMed ·Herman van der Putten, Karl‐Heinz Wiederhold, A. Probst, Samuel Barbieri, Claudia Mistl, Simone Danner, Serge Kauffmann, Katja Hofele, Will Spooren, Markus A. Rüegg, Shuo Lin, Pico Caroni, Bernd Sommer, Markus Tolnay, Graeme Bilbe	2000	420
5	Neuropathology in Mice Expressing Human α-Synuclein Journal of Neuroscience ·Herman van der Putten, Karl‐Heinz Wiederhold, A. Probst, Samuel Barbieri, Claudia Mistl, Simone Danner, Sabine Kauffmann, Katja Hofele, Will Spooren, Markus A. Rüegg, Shuo Lin, Pico Caroni, Bernd Sommer, Markus Tolnay, Graeme Bilbe	2000	393
6	A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity Acta Neuropathologica ·Zeshan Ahmed, Jane Cooper, Tracey K. Murray, Katya Garn, Emily McNaughton, Hannah F. Clarke, Samira Parhizkar, Mark Ward, Annalisa Cavallini, Samuel J. Jackson, Suchira Bose, Florence Clavaguera, Markus Tolnay, Isabelle Lavenir, Michel Goedert, Michael Hutton, Michael J. O’Neill	2014	364
7	The propagation of prion-like protein inclusions in neurodegenerative diseases Trends in Neurosciences ·Michel Goedert, Florence Clavaguera, Markus Tolnay	2010	349
8	Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid Proceedings of the National Academy of Sciences ·Michael E. Calhoun, Patrick Burgermeister, Amie L. Phinney, Martina Stalder, Markus Tolnay, Karl‐Heinz Wiederhold, Dorothée Abramowski, Christine Stürchler-Pierrat, Bernd Sommer, Matthias Staufenbiel, Mathias Jucker	1999	342
9	Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein Acta Neuropathologica ·A. Probst, Jürgen Götz, Karl‐Heinz Wiederhold, Markus Tolnay, Claudia Mistl, A.L. Jaton, Ming Hong, Takeshi Ishihara, V. M. -Y. Lee, John Q. Trojanowski, Ross Jakes, R. Anthony Crowther, M. G. Spillantini, Kurt Bürki, Michel Goedert	2000	287
10	Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy Brain ·Véronique Schaeffer, Isabelle Lavenir, Sefika Özcelik, Markus Tolnay, David T. Winkler, Michel Goedert	2012	278
11	α‐Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects Neuropathology and Applied Neurobiology ·A Bloch, A. Probst, H. Bissig, Heiner Adams, Markus Tolnay	2006	274
12	PART is part of Alzheimer disease Acta Neuropathologica ·Charles Duyckaerts, Heiko Braak, Jean‐Pierre Brion, Luc Buée, Kelly Del Tredici, Michel Goedert, Glenda M. Halliday, Manuela Neumann, Maria Grazia Spillantini, Markus Tolnay, Toshiki Uchihara	2015	247
13	Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy Journal of Neuroscience ·David T. Winkler, Luca Bondolfi, Martin C. Herzig, Lukas Jann, Michael E. Calhoun, Karl‐Heinz Wiederhold, Markus Tolnay, Matthias Staufenbiel, Mathias Jucker	2001	243
14	Induction of Tau Pathology by Intracerebral Infusion of Amyloid-β-Containing Brain Extract and by Amyloid-β Deposition in APP × Tau Transgenic Mice American Journal Of Pathology ·Tristan Bolmont, Florence Clavaguera, Melanie Meyer‐Luehmann, Martin C. Herzig, Rebecca Radde, Matthias Staufenbiel, Jada Lewis, Mike Hutton, Markus Tolnay, Mathias Jucker	2007	225
15	Lethal recessive myelin toxicity of prion protein lacking its central domain The EMBO Journal ·Frank Baumann, Markus Tolnay, Christine Brabeck, Jens Pahnke, Ulrich Kloz, Hartmut H. Niemann, Mathias Heikenwälder, Thomas Rülicke, Alexander Bürkle, Adriano Aguzzi	2007	187
16	Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice PLoS ONE ·Sefika Özcelik, Graham Fraser, Perrine Castets, Véronique Schaeffer, Zhiva Skachokova, Karin Breu, Florence Clavaguera, Michael Sinnreich, Ludwig Kappos, Michel Goedert, Markus Tolnay, David T. Winkler	2013	177
17	Two distinct immunopathological profiles in autopsy lungs of COVID-19 Nature Communications ·Ronny Nienhold, Yari Ciani, Viktor H. Koelzer, Alexandar Tzankov, Jasmin D. Haslbauer, Thomas Menter, Nathalie Schwab, Maurice Henkel, Angela Frank, Veronika Zsikla, Niels Willi, Werner Kempf, Thomas Hoyler, Mattia Barbareschi, Holger Moch, Markus Tolnay, Gieri Cathomas, Francesca Demichelis, Tobias Junt, Kirsten D. Mertz	2020	171
18	DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. PubMed ·Jan Mollenhauer, Stephan Herbertz, Uffe Holmskov, Markus Tolnay, I Krebs, Adrian Merlo, Henrik Daa Schrøder, Daniel Maier, Frank Breitling, Stefan Wiemann, H.-J. Gröne, Annemarie Poustka	2000	153
19	Pick's disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment Acta Neuropathologica ·A. Probst, Markus Tolnay, Dominique Langui, Michel Goedert, Maria Grazia Spillantini	1996	145
20	Loss of hypocretin (orexin) neurons with traumatic brain injury Annals of Neurology ·Christian R. Baumann, Claudio L. Bassetti, Philipp O. Valko, Johannes Haybaeck, Morten Keller, Erika Clark, Reto Stocker, Markus Tolnay, Thomas E. Scammell	2009	126

About Markus Tolnay

Markus Tolnay is a scholar working on Neurology, Neurology, Physiology, Cellular and Molecular Neuroscience and Genetics, having authored 124 papers that have together received 10.9k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (61 papers), Neurological diseases and metabolism (29 papers), Parkinson's Disease Mechanisms and Treatments (26 papers), Prion Diseases and Protein Misfolding (25 papers), Neuroscience and Neuropharmacology Research (10 papers), Dementia and Cognitive Impairment Research (9 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers) and Nuclear Receptors and Signaling (7 papers). The work is most often cited by research in Neurology (2.7k citations), Neurology (3.8k citations), Physiology (5.5k citations), Cellular and Molecular Neuroscience (2.4k citations) and Biological Psychiatry (156 citations). Markus Tolnay has collaborated with scholars based in Switzerland, United Kingdom and Germany. Frequent co-authors include A. Probst, Michel Goedert, Florence Clavaguera, Stephan Frank, Matthias Staufenbiel, Mathias Jucker, R. Anthony Crowther, Graham Fraser, David T. Winkler and Dorothée Abramowski. Their work appears in journals such as Acta Neuropathologica, Neuropathology and Applied Neurobiology, Brain Pathology, Advances in experimental medicine and biology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact